Literature DB >> 24552558

Nanomedicine for treatment of cancer stem cells.

Jie Gao1, Si-Shen Feng, Yajun Guo.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24552558     DOI: 10.2217/nnm.13.195

Source DB:  PubMed          Journal:  Nanomedicine (Lond)        ISSN: 1743-5889            Impact factor:   5.307


× No keyword cloud information.
  5 in total

1.  [Targeted killing of CD133+ lung cancer stem cells using paclitaxel-loaded PLGA-PEG nanoparticles with CD133 aptamers].

Authors:  L Pang; X Huang; L Zhu; H Xiao; M Li; H Guan; J Gao; H Jin
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2022-01-20

2.  The combination therapy of salinomycin and gefitinib using poly(d,l-lactic-co-glycolic acid)-poly(ethylene glycol) nanoparticles for targeting both lung cancer stem cells and cancer cells.

Authors:  Yu Zhang; Qi Zhang; Jing Sun; Huijie Liu; Qingfeng Li
Journal:  Onco Targets Ther       Date:  2017-11-27       Impact factor: 4.147

3.  Codelivery of doxorubicin and elacridar to target both liver cancer cells and stem cells by polylactide-co-glycolide/d-alpha-tocopherol polyethylene glycol 1000 succinate nanoparticles.

Authors:  Dazhong Chen; Xiaoli Pan; Fangyuan Xie; Ying Lu; Hao Zou; Chuan Yin; Yu Zhang; Jie Gao
Journal:  Int J Nanomedicine       Date:  2018-10-25

4.  Polymer-lipid hybrid anti-HER2 nanoparticles for targeted salinomycin delivery to HER2-positive breast cancer stem cells and cancer cells.

Authors:  Jun Li; Wenqing Xu; Xiaoli Yuan; Huaiwen Chen; Hao Song; Bingquan Wang; Jun Han
Journal:  Int J Nanomedicine       Date:  2017-09-18

5.  Gefitinib-loaded DSPE-PEG2000 nanomicelles with CD133 aptamers target lung cancer stem cells.

Authors:  Xiaolong Huang; Jingsong Huang; Dewen Leng; Shuo Yang; Qi Yao; Jin Sun; Jun Hu
Journal:  World J Surg Oncol       Date:  2017-08-30       Impact factor: 2.754

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.